Glycosylated recombinant human XCL1/lymphotactin exhibits enhanced biologic activity

Chen Dong, Annabelle Chua, Bishu Ganguly, Alan M. Krensky, Carol Clayberger*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

21 Scopus citations


Chemokines are a family of small, secreted chemoattractant cytokines that regulate distribution and function of leukocytes during immune responses. While most chemokines are members of the CC or CXC subgroups, XCL1, also known as lymphotactin, is the sole member of the C subgroup. XCL1 is produced by activated CD8+ T cells, NK cells, γδ T cells, and mast cells. XCL1 differs from other chemokines in that it contains only a single disulfide bond and a mucin-like domain at its carboxy terminus that is glycosylated. Understanding the biologic functions of chemokines has largely depended upon expression of these recombinant molecules in E. coli. To examine the effects of glycosylation on the biologic activity of XCL1, we designed constructs for expression of human XCL1 in insect S2 cells. Comparison of this material with that expressed in E. coli reveals that glycosylation significantly increases the biologic activity of XCL1.

Original languageEnglish (US)
Pages (from-to)136-144
Number of pages9
JournalJournal of Immunological Methods
Issue number1-2
StatePublished - Jul 2005


  • Chemokine
  • Glycosylation
  • Insect cells
  • Lymphotactin
  • Protein expression
  • XCL1

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Glycosylated recombinant human XCL1/lymphotactin exhibits enhanced biologic activity'. Together they form a unique fingerprint.

Cite this